AUDIT OF ANTI-TUMOUR NECROSIS FACTOR THERAPY IN CROHN'S DISEASE: BETTER RESULTS IN PATIENTS WITH NO PREVIOUS SURGERY

被引：0
|
作者：
Patel, R. N. [1 ]
Gregg, B. [1 ]
Kneebone, A. [1 ]
Leiper, K. P. [1 ]
Ellis, A. [1 ]
Watson, A. J. [1 ]
Rhodes, J. M. [1 ]
机构：
[1] Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England
来源：
GUT | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A99 / A100
页数：2
相关论文
共 50 条
  • [21] The future role of anti-tumour necrosis factor-α products in the treatment of Crohn's disease
    van Hogezand, RA
    Verspaget, HW
    DRUGS, 1998, 56 (03) : 299 - 305
  • [22] Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease
    Busquets, David
    Mas-de-Xaxars, Teresa
    Lopez-Siles, Mireia
    Martinez-Medina, Margarita
    Bahi, Anna
    Sabat, Miriam
    Louvriex, Rene
    Oriol Miquel-Cusachs, Josep
    Garcia-Gil, Jesus L.
    Aldeguer, Xavier
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (10): : 899 - 906
  • [23] The Future Role of Anti-Tumour Necrosis Factor-α Products in the Treatment of Crohn's Disease
    Ruud A. van Hogezand
    Hein W. Verspaget
    Drugs, 1998, 56 : 299 - 305
  • [24] Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
    Sprakes, Michael B.
    Hamlin, P. John
    Warren, Lisa
    Greer, Dan
    Ford, Alexander C.
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (04): : 324 - 331
  • [25] ANTI-TUMOUR NECROSIS FACTOR COST-SAVING AUDIT
    Suresh, Resmy
    Kiely, Patrick
    RHEUMATOLOGY, 2017, 56 : 194 - 194
  • [26] Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?
    Bhalme, Mahesh
    Sharma, Abhishek
    Keld, Richard
    Willert, Robert
    Campbell, Simon
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (05) : 543 - 549
  • [27] Impact of Anti-Tumour Necrosis Factor Therapy on the Insulin Like Growth Factor Axis and Bone Development in Childhood Crohn's Disease
    Altowati, M.
    Malik, S.
    Shepherd, S.
    McMillan, M.
    McGrogan, P.
    Ahmed, S. F.
    Wong, S. C.
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 180 - 180
  • [28] Efficacy and safety of ustekinumab in patients with Crohn's disease refractory to anti-tumour necrosis factor: real clinical practice
    Saiz Chumillas, R. M.
    Alba Hernandez, L.
    Chivato Martin-Falquina, I.
    Badia Aranda, E.
    Arias Garcia, M. L.
    Sicilia Aladren, B.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S400 - S401
  • [29] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Konstantinos Papamichael
    Severine Vermeire
    World Journal of Gastroenterology, 2015, (16) : 4773 - 4778
  • [30] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Papamichael, Konstantinos
    Vermeire, Severine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (16) : 4773 - 4778
12345